18.21

2.36% 0.42

After Hours: 18.16 -0.05 -0.27%

Stevanato Group Spa (STVN)

Overview News Price History Option Chain Why STVN Down? Discussions Forecast Dividend History

Stevanato Group Spa stock is traded at $18.21, with a volume of 446.64K. It is up +2.36% in the last 24 hours and up +32.63% over the past month. Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Previous Close:

$17.79

Open:

$18.12

24h Volume:

446.64K

Relative Volume:

0.68

Market Cap:

$4.97B

Revenue:

$1.35B

Net Income/Loss:

$159.12M

P/E Ratio:

31.23

EPS:

0.5831

Net Cash Flow:

$12.86M

1W Performance:

+12.34%

1M Performance:

+32.63%

6M Performance:

-27.16%

1Y Performance:

-17.71%

1-Day Range:

$17.84

$18.40

1-Week Range:

$15.95

$18.40

52-Week Range:

$12.89

$28.00

Stevanato Group Spa Stock (STVN) Company Profile

Name

Stevanato Group Spa

Sector

Healthcare (1106)

Industry

Medical Instruments & Supplies (56)

Phone

Address

Employee

5,795

Twitter

Next Earnings Date

2026-05-07

Latest SEC Filings

STVN's Discussions on Twitter

Compare STVN vs ISRG, BDX, MDLN, ALC, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STVN Stevanato Group Spa	18.21	4.86B	1.35B	159.12M	12.86M	0.5831
ISRG Intuitive Surgical Inc	451.38	160.21B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	144.17	41.62B	21.92B	1.76B	2.63B	6.1223
MDLN Medline Inc	45.32	37.37B	28.43B	1.16B	1.26B	1.4457
ALC Alcon Inc	74.45	35.82B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	207.88	30.38B	5.40B	1.49B	1.78B	10.12

Stevanato Group Spa Stock (STVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Resumed	Morgan Stanley	Equal-Weight
Dec-13-24	Initiated	Wolfe Research	Outperform
Dec-03-24	Resumed	Morgan Stanley	Equal-Weight
Apr-22-24	Initiated	Exane BNP Paribas	Outperform
Nov-01-23	Downgrade	Jefferies	Buy → Hold
Sep-26-23	Initiated	Stephens	Overweight
Sep-19-23	Initiated	CJS Securities	Market Outperform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-10-21	Initiated	BofA Securities	Buy
Aug-10-21	Initiated	Citigroup	Buy
Aug-10-21	Initiated	Jefferies	Buy
Aug-10-21	Initiated	KeyBanc Capital Markets	Overweight
Aug-10-21	Initiated	Morgan Stanley	Overweight
Aug-10-21	Initiated	Wells Fargo	Overweight

View All

Stevanato Group Spa Stock (STVN) Latest News

May 05, 2026

Stevanato Group to Participate in Three Upcoming Investor ConferencesMay 4, 2026 - BioSpace

May 05, 2026

May 04, 2026

Why (STVN) Price Action Is Critical for Tactical Trading - Stock Traders Daily

May 04, 2026

Stevanato Group S.p.A. (NYSE:STVN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

May 04, 2026

May 02, 2026

Jennison Associates LLC Buys 213,602 Shares of Stevanato Group S.p.A. $STVN - MarketBeat

May 02, 2026

May 01, 2026